PROBLEM: Gestational genitourinary infections are associated with lifelong disabilities, but it is unknown if neonatal inflammation is involved. METHOD: Mothers of 914 infants born before 28th gestation week reported cervical/vaginal infection (CVI), and/or urine/bladder/kidney infection (UTI), or neither. Inflammation proteins measured in baby's blood on postnatal days 1, 7, and 14 were considered elevated if in the top quartile for gestational age. Logistic regression models adjusting for potential confounders assessed odds ratios. RESULTS: Compared to mothers with neither UTI/CVI, those with CVI were more likely to have infants with elevated CRP, SAA, MPO, IL-1β, IL-6, IL-6R, TNF-α, RANTES, ICAM-3, E-selectin, and VEGF-R2 on day 1; those with UTI were more likely to have infants with elevated MPO, IL-6R, TNF-R1, TNF-R2, and RANTES on day 7. Placental anaerobes and genital mycoplasma were more common in pregnancies with CVI. CONCLUSION: Gestational UTI/CVI should be targeted for preventing systemic inflammation in the very preterm newborn.
PROBLEM: Gestational genitourinary infections are associated with lifelong disabilities, but it is unknown if neonatal inflammation is involved. METHOD: Mothers of 914 infants born before 28th gestation week reported cervical/vaginal infection (CVI), and/or urine/bladder/kidney infection (UTI), or neither. Inflammation proteins measured in baby's blood on postnatal days 1, 7, and 14 were considered elevated if in the top quartile for gestational age. Logistic regression models adjusting for potential confounders assessed odds ratios. RESULTS: Compared to mothers with neither UTI/CVI, those with CVI were more likely to have infants with elevated CRP, SAA, MPO, IL-1β, IL-6, IL-6R, TNF-α, RANTES, ICAM-3, E-selectin, and VEGF-R2 on day 1; those with UTI were more likely to have infants with elevated MPO, IL-6R, TNF-R1, TNF-R2, and RANTES on day 7. Placental anaerobes and genital mycoplasma were more common in pregnancies with CVI. CONCLUSION: Gestational UTI/CVI should be targeted for preventing systemic inflammation in the very preterm newborn.
Authors: Carl Bose; Matthew Laughon; Elizabeth N Allred; Linda J Van Marter; T Michael O'Shea; Richard A Ehrenkranz; Raina Fichorova; Alan Leviton Journal: Pediatr Res Date: 2011-04 Impact factor: 3.756
Authors: B H Yoon; R Romero; J Moon; T Chaiworapongsa; J Espinoza; Y M Kim; S Edwin; J C Kim; N Camacho; E Bujold; R Gomez Journal: J Matern Fetal Neonatal Med Date: 2003-01
Authors: Karl C K Kuban; T Michael O'Shea; Elizabeth N Allred; Nigel Paneth; Deborah Hirtz; Raina N Fichorova; Alan Leviton Journal: J Child Neurol Date: 2014-03-18 Impact factor: 1.987
Authors: Elizabeth N Allred; Olaf Dammann; Raina N Fichorova; Stephen R Hooper; Scott J Hunter; Robert M Joseph; Karl Kuban; Alan Leviton; Thomas Michael O'Shea; Megan N Scott Journal: J Neuroimmune Pharmacol Date: 2017-04-12 Impact factor: 4.147
Authors: Robert M Joseph; Steven J Korzeniewski; Elizabeth N Allred; T Michael O'Shea; Tim Heeren; Jean A Frazier; Janice Ware; Deborah Hirtz; Alan Leviton; Karl Kuban Journal: Am J Obstet Gynecol Date: 2016-11-12 Impact factor: 8.661
Authors: Matthew Josiah Allen-Daniels; Myrna G Serrano; Lindsey P Pflugner; Jennifer M Fettweis; Melissa A Prestosa; Vishal N Koparde; J Paul Brooks; Jerome F Strauss; Roberto Romero; Tinnakorn Chaiworapongsa; David A Eschenbach; Gregory A Buck; Kimberly K Jefferson Journal: Am J Obstet Gynecol Date: 2015-01-28 Impact factor: 8.661
Authors: Alan Leviton; Robert M Joseph; Raina N Fichorova; Elizabeth N Allred; H Gerry Taylor; T Michael O'Shea; Olaf Dammann Journal: J Neuroimmune Pharmacol Date: 2018-09-06 Impact factor: 4.147
Authors: Maheer Faden; Mari Holm; Elizabeth Allred; Raina Fichorova; Olaf Dammann; Alan Leviton Journal: Cytokine Date: 2016-09-24 Impact factor: 3.861
Authors: Benjamin J S Al-Haddad; Elizabeth Oler; Blair Armistead; Nada A Elsayed; Daniel R Weinberger; Raphael Bernier; Irina Burd; Raj Kapur; Bo Jacobsson; Caihong Wang; Indira Mysorekar; Lakshmi Rajagopal; Kristina M Adams Waldorf Journal: Am J Obstet Gynecol Date: 2019-06-15 Impact factor: 8.661
Authors: Mari Holm; Dordi Austeng; Raina N Fichorova; Elizabeth N Allred; Karl C Kuban; T Michael O'Shea; Olaf Dammann; Alan Leviton Journal: Acta Paediatr Date: 2017-01-25 Impact factor: 2.299
Authors: Alan Leviton; Elizabeth N Allred; Raina N Fichorova; Karl C K Kuban; T Michael O'Shea; Olaf Dammann Journal: Acta Paediatr Date: 2015-12-23 Impact factor: 2.299
Authors: Alan Leviton; Elizabeth N Allred; Raina N Fichorova; Karl C K Kuban; T Michael O'Shea; Olaf Dammann Journal: Early Hum Dev Date: 2015-12-28 Impact factor: 2.079
Authors: Alan Leviton; Elizabeth N Allred; Raina N Fichorova; Deborah K VanderVeen; T Michael O'Shea; Karl Kuban; Olaf Dammann Journal: Am J Perinatol Date: 2019-01-27 Impact factor: 1.862